{
    "2019-09-11": [
        [
            {
                "time": "2019-09-11",
                "original_text": "【IPO追踪】复星旗下复宏汉霖(02696-HK)明起招股入场费5838港元",
                "features": {
                    "keywords": [
                        "IPO",
                        "复宏汉霖",
                        "招股",
                        "入场费"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-09-11",
                "original_text": "【异动股】单抗概念板块下挫，九洲药业(603456-CN)跌5.87%",
                "features": {
                    "keywords": [
                        "单抗概念",
                        "九洲药业",
                        "下跌"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-09-11",
                "original_text": "复宏汉霖明天启动招股 卡塔尔投资局及高管成为基石投资者",
                "features": {
                    "keywords": [
                        "复宏汉霖",
                        "招股",
                        "卡塔尔投资局",
                        "基石投资者"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-09-11",
                "original_text": "复星医药(600196.SH)：复宏汉霖更新聆讯后资料集",
                "features": {
                    "keywords": [
                        "复星医药",
                        "复宏汉霖",
                        "聆讯后资料集"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-09-11",
                "original_text": "医药业转型提速 创新发展添彩“健康中国”",
                "features": {
                    "keywords": [
                        "医药业",
                        "转型",
                        "创新发展",
                        "健康中国"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-09-11",
                "original_text": "【IPO追踪】复星医药(02196-HK)拟分拆复宏汉霖主板上市",
                "features": {
                    "keywords": [
                        "IPO",
                        "复星医药",
                        "复宏汉霖",
                        "分拆",
                        "主板上市"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-09-11",
                "original_text": "【金财富决策参考】2019-09-11",
                "features": {
                    "keywords": [
                        "金财富",
                        "决策参考"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}